Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals

Expert Opinion on Drug Delivery

Volumn 9, Issue 4, 2012, Pages 429-441

  Puglia, Carmelo ^a   Bonina, Francesco ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Lipids; Nanostructured lipid carriers; Nanotechnology; Solid lipid nanoparticles; Topical delivery

Indexed keywords

BENZOCAINE; BERGAPTEN; BETAMETHASONE VALERATE; CALCIPOTRIOL; CHOLIC ACID; CLOTRIMAZOLE; CORTICOSTEROID; CYPROTERONE ACETATE; ECONAZOLE; ETRETIN; FLURBIPROFEN; INDOMETACIN; KETOROLAC; LIDOCAINE; METHOTREXATE; METHOXSALEN; MICONAZOLE; MINOXIDIL; PHOSPHATIDYLCHOLINE; POLOXAMER; POLYSORBATE 20; POLYSORBATE 80; PREDNICARBATE; PREDNISOLONE; RETINOIC ACID; SOLID LIPID NANOPARTICLE; SQUALENE; TACROLIMUS; TYLOXAPOL; UNINDEXED DRUG;

ACNE; ANTIINFLAMMATORY ACTIVITY; AQUEOUS SOLUTION; ATOPIC DERMATITIS; BIOCOMPATIBILITY; BIODEGRADATION; CHEMICAL ANALYSIS; CONCENTRATION RESPONSE; CORTICOSTEROID THERAPY; DANDRUFF; DERMATITIS; DERMATOMYCOSIS; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG INDUSTRY; DRUG PENETRATION; DRUG SOLUBILITY; EDEMA; EMULSION; EPIDERMIS; HUMAN; HYDROPHILICITY; MUSCULOSKELETAL DISEASE; NANOEMULSION; NONHUMAN; PARTICLE SIZE; PHOTODEGRADATION; PSORIASIS; PUVA; QUALITY OF LIFE; REVIEW; SKIN DISEASE; SKIN INFECTION; SKIN IRRITATION; SKIN PENETRATION; STRATUM CORNEUM; TOPICAL TREATMENT;

ACNE VULGARIS; ADMINISTRATION, CUTANEOUS; ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIFUNGAL AGENTS; COSMETICS; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; DRUG CARRIERS; DRUG STABILITY; EMULSIONS; EXCIPIENTS; HUMANS; LIGHT; LIPIDS; MYCOSES; NANOPARTICLES; PSORIASIS; SKIN; SKIN DISEASES;

EID: 84858858095     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2012.666967     Document Type: Review

References (84)

1. Vauthier C, Bouchemal K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharm Res 2009;26:1025-58
2. Vega-Villa K, Takemoto JK, Yanez JA, et al. Clinical toxicities of nanocarrier systems. Adv Drug Deliv Rev 2008;60:929-38
3. Muller RH, Mehnert W, Lucks JS, et al. Solid lipid nanoparticles (SLN)-An alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm 1995;41:62-9
4. Gasco MR. Method for producing solid lipid microspheres having a narrow size distribution. US188837; 1993
5. Schwarz C, Mehnert W, Lucks JS, Muller RH. Solid lipid nanoparticles (SLN) for controlled drug delivery: I. Production, characterization and sterilization. J Control Release 1994;30:83-96, First article on SLN
6. Mehnert W, Mader K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev 2001;47:165-96
7. Bunjes HWK, Kock MHJ. Crystallization tendency and polymorphic transitions in trigliceride nanoparticles. Int J Pharm 1996;129:159-73
8. Freitas C, Muller RH. Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase. Eur J Pharm Biopharm 1999;47:125-32
9. Muller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 2002;242:121-8 An interesting paper introducing NLC.
10. Pardeike J, Hommoss A, Muller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 2009;366:170-84
11. Ricci M, Puglia C, Bonina F, et al. Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): In vitro and in vivo studies. J Pharm Sci 2005;94:1149-59
12. Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002;54:S131-55 A very interesting paper to deeply understand the difference between SLN and NLC and their potential in cosmetic and dermatological fields.
13. Sjostrom B, Bergenstahl B. Preparation of sub micron drug particles in lecithin-stabilized o/w emulsions. I. Model studies of the precipitation of cholesteryl acetate. Int J Pharm 1992;88:53-62
14. Siekmann B, Westesen K. Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions. Eur J Pharm Biopharm 1996;43:104-9
15. Dingler A, Blum RP, Niehus H, et al. Solid lipid nanoparticles (SLN/Lipopearls). A pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products. J Microencapsul 1999;16:751-67
16. Trombino S, Cassano R, Muzzalupo R, et al. Stearyl ferulate-based solid lipid nanoparticles for the encapsulation and stabilization of beta -carotene and alpha - Tocopherol. Colloid Surf B 2009;72:181-7
17. Kristl J, Volk B, Gasperlin M, et al. Effect of colloidal carriers on ascorbyl palmitate stability. Eur J Pharm Sci 2003;19:181-9
18. Uener M, Wissing SA, Yener G, et al. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for application of ascorbyl palmitate. Pharmazie 2005;60:577-82
19. Grabnar PA, Zajc N, Kristl J. Improvement of ascorbyl palmitate stability in lipid nanoparticle dispersions for dermal use. J Drug Deliv Sci Technol 2006;16:443-8
20. Teeranachaideekul V, Muller RH, Junyaprasert VB. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)-Effects of formulation parameters on physicochemical stability. Int J Pharm 2007;340:198-206
21. Shah KA, Date AA, Joshi MD, et al. Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical delivery. Int J Pharm 2007;345:163-71
22. Lee CM, Jeong HJ, Park JW, et al. Temperature-induced release of all-trans-retinoic acid loaded in solid lipid nanoparticles for topical delivery. Macromol Res 2008;16:682-5
23. Jenning V, Gohla SH. Encapsulation of retinoids in solid lipid nanoparticles (SLN). J Microencapsul 2001;18:149-58
24. Jee JP, Lim SJ, Park JS, et al. Stabilization of all-trans retinol by loading lipophilic antioxidants in solid lipid nanoparticles. Eur J Pharm Biopharm 2006;63:134-9
25. Hentschel A, Gramdorf S, Muller RH, et al. beta -Carotene-loaded nanostructured lipid carriers. J Food Sci 2008;73:N1-6
26. Souto EB, Muller RH, Gohla S. A novel approach based on lipid nanoparticles (SLN) for topical delivery of alpha - lipoic acid. J Microencapsul 2005;22:581-92
27. Ruktanonchai U, Bejrapha P, Sakulkhu U, et al. Physicochemical characteristics, cytotoxicity, and antioxidant activity of three lipid nanoparticulate formulations of alpha-lipoic acid. AAPS PharmSciTech 2009;10:227-34
28. Mitri K, Shegokar R, Gohla S, et al. Lipid nanocarriers for dermal delivery of lutein: Preparation, characterization, stability and performance. Int J Pharm 2011;414:267-75
29. Nikolic S, Gohla S, Muller RH. Lipid nanoparticles: Nanocarriers for more effective and safer photoprotective products. Expert Rev Dermatol 2011;6:501-7
30. Durand L, Habran N, Henschel V, et al. Encapsulation of ethylhexyl methoxycinnamate, a light-sensitive UV filter, in lipid nanoparticles. J Microencapsul 2010;27:714-25
31. Puglia C, Bonina F, Rizza L, et al. Lipid nanoparticles as carrier for octylmethoxycinnamate: In vitro percutaneous absorption and photostability studies. J Pharm Sci 2011;101:301-11
32. Jenning V, Gysler A, Schafer-Korting M, et al. Vitamin A loaded solid lipid nanoparticles for topical use: Occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm 2000;49:211-18 An investigation on occlusive properties of solid lipid nanoparticles for cosmetic applications.
33. Wissing S, Lippacher A, Muller RH. Investigations on the occlusive properties of solid lipid nanoparticles (SLN). J Cosmet Sci 2001;52:313-24
34. Junyaprasert VB, Teeranachaideekul V, Souto EB, et al. Q10-loaded NLC versus nanoemulsions: Stability, rheology and in vitro skin permeation. Int J Pharm 2009;377:207-14
35. Pardeike J, Muller RH. Coenzyme Q10-loaded NLCs: Preparation, occlusive properties and penetration enhancement. Pharm Tech Eur 2007;19:46-9
36. Muller RH, Petersen RD, Hommoss A, et al. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev 2007;59:522-30
37. Jain S, Chourasia MK, Masuriha R, et al. Solid lipid nanoparticles bearing flurbiprofen for transdermal delivery. Drug Deliv 2005;12:207-15
38. Pople PV, Singh KK. Development and evaluation of topical formulation containing solid lipid nanoparticles of Vitamin A. AAPS PharmSciTech 2006;7:E63-9
39. Bunjes H, Steiniger F, Richter W. Visualizing the structure of triglyceride nanoparticles in different crystal modifications. Langmuir 2007;23:4005-11
40. Blasi P, Schoubben A, Giovagnoli S, et al. The real value of novel particulate carriers for sunscreen formulation. Expert Rev Dermatol 2011;6:509-17
41. Wissing SA, Muller RH. The development of an improved carrier system for sunscreen formulations based on crystalline lipid nanoparticles. Int J Pharm 2002;242:373-5
42. Wissing SA, Muller RH. Solid lipid nanoparticles as carrier for sunscreens: In vitro release and in vivo skin penetration. J Control Release 2002;81:225-33 This article shows the importance of lipid nanoparticles in the formulation of innovative sun filter products.
43. Xia Q, Saupe A, Muller RH, et al. Nanostructures lipid carriers as novel carrier for sunscreen formulations. Int J Cosmet Sci 2007;29:473-82
44. Nikolic S, Keck CM, Anselmi C, et al. Skin photoprotection improvement: Synergistic interaction between lipid nanoparticles and organic UV filters. Int J Pharm 2011;414:276-84
45. Iscan Y, Wissing SA, Hekimoglu S, et al. Solid lipid nanoparticles (SLN) for topical drug delivery: Incorporation of the lipophilic drugs N,N-diethyl-mtoluamide and vitamin K. Pharmazie 2005;60:905-9
46. Puglia C, Bonina F, Castelli F, et al. Evaluation of percutaneous absorption of the repellent diethyltoluamide and the sunscreen ethylhexyl p-methoxycinnamate-loaded solid lipid nanoparticles: An in-vitro study. J Pharm Pharmacol 2009;61:1013-19
47. Maia CS, Mehnert W, Schafer-Korting M. Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int J Pharm 2000;196:165-7
48. Maia CS, Mehnert W, Schaller M, et al. Drug targeting by solid lipid nanoparticles for dermal use. J Drug Target 2002;10:489-95
49. Sivaramakrishnan R, Nakamura C, Mehnert W, et al. Glucocorticoid entrapment into lipid carriers - characterization by parelectric spectroscopy and influence on dermal uptake. J Control Release 2004;97:493-502
50. Jensen LB, Magnusson E, Gunnarsson L, et al. Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles. Int J Pharm 2010;390:53-60
51. Jensen LB, Petersson K, Nielsen HM. In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin. Eur J Pharm Biopharm 2011; 79:68-75
52. Zhang J, Smith E. Percutaneous permeation of betamethasone 17-valerate incorporated in lipid nanoparticles. J Pharm Sci 2011;100:896-903
53. Schlupp P, Blaschke T, Kramer KD, et al. Drug Release and skin penetration from solid lipid nanoparticles and a base cream: A systematic approach from a comparison of three glucocorticoids. Skin Pharmacol Physiol 2011; 24:199-209
54. Castelli F, Puglia C, Sarpietro MG, et al. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Int J Pharm 2005;304:231-8
55. Puglia C, Filosa R, Peduto A, et al. Evaluation of alternative strategies to optimize ketorolac transdermal delivery. AAPS PharmSciTech 2006;7:64
56. Bhaskar K, Anbu J, Ravichandiran V, et al. Lipid nanoparticles for transdermal delivery of flurbiprofen: Formulation, in vitro, ex vivo and in vivo studies. Lipids Health Dis 2009;8:6
57. Gonzalez-Mira E, Nikolic S, Garcia ML, et al. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen. J Pharm Sci 2011;100:242-51
58. Puglia C, Blasi P, Rizza L, et al. Lipid nanoparticles for prolonged topical delivery: An in vitro and in vivo investigation. Int J Pharm 2008;357:295-304
59. Joshi M, Patravale V. Formulation and evaluation of Nanostructured Lipid Carrier (NLC)-based gel of Valdecoxib. Drug Dev Ind Pharm 2006;32:911-18
60. Joshi M, Patravale V. Nanostructured lipid carrier (NLC) based gel of celecoxib. Int J Pharm 2008; 346:124-32
61. Date AA, Naik B, Nagarsenker MS. Novel drug delivery systems: Potential in improving topical delivery of antiacne agents. Skin Pharmacol Physiol 2006;19:2-16
62. Munster U, Nakamura C, Haberland A, et al. Ru58841-myristate-prodrug development for topical treatment of acne and androgenic alopecia. Pharmazie 2005;60:8-12
63. Stecova J, Mehnert W, Blaschke T, et al. Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: Particle characterization and skin uptake. Pharm Res 2007;24:991-1000
64. Schaefer-Korting M, Mehnert W, Korting HC. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev 2007;59:427-43
65. Mandawgade SD, Patravale VB. Development of SLNs from natural lipids: Application to topical delivery of tretinoin. Int J Pharm 2008;363:132-8
66. Liu J, Hu W, Chen H, et al. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm 2007;328:191-5
67. Castro GA, Orefice RL, Vilela JMC, et al. Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne. J Microencapsul 2007;24:395-407
68. Castro GA, Oliveira CA, Mahecha GAB, et al. Comedolytic effect and reduced skin irritation of a new formulation of all-trans retinoic acid-loaded solid lipid nanoparticles for topical treatment of acne. Arch Dermatol Res 2011;303:513-20
69. Kaur IP, Kakkar S. Topical delivery of antifungal agents. Expert Opin Drug Deliv 2010;7:1303-27
70. Souto EB, Wissing SA, Barbosa CM, et al. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 2004;278:71-7
71. Souto EB, Muller R. The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents. Pharmazie 2006;61:431-7
72. Souto EB, Muller RH. Rheological and in vitro release behaviour of clotrimazole-containing aqueous solid lipid nanoparticle dispersions and commercial creams. Pharmazie 2007;62:505-9
73. Sanna V, Gavini E, Cossu M, et al. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: In-vitro characterization, ex-vivo and in-vivo studies. J Pharm Pharmacol 2007;59:1057-64
74. Passerini N, Gavini E, Albertini B, et al. Evaluation of solid lipid microparticles produced by spray congealing for topical application of econazole nitrate. J Pharm Pharmacol 2009;61:559-67
75. Bhalekar MR, Pokharkar V, Madgulkar A, et al. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. AAPS PharmSciTech 2009;10:289-96
76. Jain S, Jain S, Khare P, et al. Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent. Drug Deliv 2010;17:443-51
77. Fang JY, Fang CL, Liu CH, et al. Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm 2008;70:633-40
78. Agrawal Y, Petkar KC, Sawant KK. Development, evaluation and clinical studies of acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. Int J Pharm 2010;401:93-102 A well-conducted clinical study to evaluate the efficacy of NLC in dermal drug delivery.
79. Lin YK, Huang ZR, Zhuo RZ, et al. Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int J Nanomed 2010;5:117-28
80. Katoh N. Future perspectives in the treatment of atopic dermatitis. J Dermatol 2009;36:367-76
81. Pople PV, Singh KK. Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis. Int J Pharm 2010;398:165-78
82. Silva AC, Santos D, Ferreira DC, et al. Minoxidil-loaded nanostructured lipid carriers (NLC): Characterization and rheological behaviour of topical formulations. Pharmazie 2009;64:177-82
83. Padois K, Cantieni C, Bertholle V, et al. Solid lipid nanoparticles suspension versus commercial solutions for dermal delivery of minoxidil. Int J Pharm 2011;416:300-4
84. Puglia C, Sarpietro MG, Bonina F, et al. Development, characterization, and in vitro and in vivo evaluation of benzocaine- And lidocaine-loaded nanostructured lipid carriers. J Pharm Sci 2011;100:1892-9